Operating Responsibly

Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we collect are used safely, ethically, and responsibly.

Videos from this campaign

Content from this campaign

Research, Reports & Publications

Illumina CEO Highlights the Company’s Efforts To Leverage Genomics for Good
We entered 2021 full of hope for a recovery from the pandemic, at the dawn of a new era of genomic medicine, and a recognition of the incredible opportunities for us to rebuild a healthier, more inclusive, and more sustainable global community.

Awards, Ratings & Rankings

Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category
Illumina has been included for the first time on the 2022 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest U.S. public companies.

Health & Healthcare

World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says
Two years into the pandemic that has killed millions and shaken the global economy, the world still lacks a unified effort to detect and fight future outbreaks using genetic tools, said Illumina Inc. Chief Executive Officer Francis deSouza.

Research, Reports & Publications

Illumina Releases Annual Corporate Social Responsibility Report
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today released its annual Corporate Social Responsibility (CSR) Report, highlighting the company's 2021 environmental, social, and governance (ESG) program and commitment to human health.

Awards, Ratings & Rankings

Illumina Earns Gold Class in the S&P Global's 2022 Sustainability Yearbook
Our ESG commitments and actions support our goal for a global health transformation.

Awards, Ratings & Rankings

Illumina Named One of America's Most JUST Companies for Third Consecutive Year
We are honored to be recognized as #32 by CNBC and JUST Capital in the Americas Most JUST rankings and #1 for customers in the Pharmaceuticals and Biotech industry.

Awards, Ratings & Rankings

Illumina Ranked #2 on Newsweek's America's Most Responsible Companies 2022 List
We are delighted that Illumina is the top ranked Healthcare and Life Science company and #2 overall on Newsweek’s America’s Most Responsible Companies 2022 list, which recognizes top-performing companies that are making a difference through their environmental, social and governance actions.

Awards, Ratings & Rankings

Illumina Named to 2021 Dow Jones Sustainability Indices With Highest Score in Pharmaceuticals, Biotechnology and Life Sciences Industry
We’re honored to be named to the prestigious S&P Global’s Dow Jones Sustainability Index (DJSI) for a 3rd year in a row.

Awards, Ratings & Rankings

Illumina Recognized As #20 on Fortune's Change the World List
Each year, Fortune Magazine publishes their ChangeTheWorld list to celebrate companies and leaders that embrace corporate purpose and have had a positive social impact

Awards, Ratings & Rankings

Illumina Is One of the 2021 TIMES Most Influential Companies
“We need global co-operation to come together on a number of fronts,” says deSouza. The first challenge, he says, is creating a global network that scans and shares information on disease-causing pathogens.
Illumina logo

More from Illumina

  1. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  2. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  3. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  4. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  5. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...